Charlie joined UCLPartners in 2009 as Stroke Lead and subsequently took on the role of Programme Director for Neurosciences. He became Director of the AHSN in 2014 and Managing Director in May 2015. In October 2016, Charlie was appointed as Interim Managing Director for UCLPartners. Charlie provides strategic leadership for the AHSN and its integrated programmes, as well as providing leadership across UCLPartners. Before joining UCLPartners, Charlie was the clinical lead for stroke services at the Royal Free London NHS Foundation Trust, where he continues his clinical work as Consultant Neurologist. He has also been the stroke lead for the North Central London Cardiovascular and Stroke Network. Charlie played a pivotal role in redesigning stroke services in London, which has resulted in significantly improved outcomes. He has published extensively in several areas of clinical neurology. His current research interests include service reconfiguration and clinical outcomes. He has been an editor of The European Journal of Neurology for over 10 years and serves on the board of the UCL Institute of Digital Health and DigitalHealth.London. Charlie recently represented the 15 AHSNs on the Government’s Life Sciences Cabinet.